Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
1(11%)
Results Posted
33%(2 trials)

Phase Distribution

Ph not_applicable
3
33%
Ph phase_1
2
22%
Ph phase_2
1
11%
Ph phase_3
3
33%

Phase Distribution

2

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
2(22.2%)
Phase 2Efficacy & side effects
1(11.1%)
Phase 3Large-scale testing
3(33.3%)
N/ANon-phased studies
3(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(6)
Other(1)

Detailed Status

Completed6
Not yet recruiting1
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (22.2%)
Phase 21 (11.1%)
Phase 33 (33.3%)
N/A3 (33.3%)

Trials by Status

not_yet_recruiting111%
completed667%
recruiting111%
unknown111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DRUG
Total Trials
9